Fulgent Genetics (FLGT) Net Income towards Common Stockholders Growth (1y) (2016 - 2026)
Powered by 
Analysis
Fulgent Genetics (FLGT) Net Income towards Common Stockholders Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 33.71% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 12.89% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 25.51% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -20.26% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 119.85% |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 99.88% |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 573.74% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 3,367.34% |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 36.67% |
| 10 | Fulgent Genetics | 596.80 Mn | 334.14 Mn | 25.68 Mn | -55.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -55.77% |
| Mar 31, 2026 | -115.32% |
| Dec 31, 2025 | -297.72% |
| Sep 30, 2025 | 54.89% |
| Jun 30, 2025 | -117.65% |
| Mar 31, 2025 | 14.35% |
| Dec 31, 2024 | 95.41% |
| Sep 30, 2024 | -11.76% |
| Jun 30, 2024 | 22.43% |
| Mar 31, 2024 | 12.24% |
| Dec 31, 2023 | -432.27% |
| Sep 30, 2023 | -1,075.95% |
| Jun 30, 2023 | -201.60% |
| Mar 31, 2023 | -109.99% |
| Dec 31, 2022 | -123.22% |
| Sep 30, 2022 | -98.90% |
| Jun 30, 2022 | -85.44% |
| Mar 31, 2022 | -23.49% |
| Dec 31, 2021 | -38.26% |
| Sep 30, 2021 | 147.33% |